Manuscripts

Search by keyword, year, or author name.

Showing 1595 manuscripts.

Association of site-specific and participant-specific factors with retention of children in a long-term pediatric HIV cohort study.

Paige L. Williams, Ph.D., Russell B. Van Dyke, M.D., Michelle L. Eagle, P.A.-C., Dorothy Smith, M.S., C.P.N.P., Carol A. Vincent, C.R.N.P., M.S.N, Gregory Ciupak, B.A., James M. Oleske, M.D., George Seage, III, Sc.D., M.P.H. Association of site-specific and participant-specific factors with retention of children in a long-term pediatric HIV cohort study. American Journal Of Epidemiology. 2008 Jun 01; 167(11):1375-86. PMID: 18413359; PMCID: PMC2862644.

Year

2008

Journal

American Journal Of Epidemiology

Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results.

Ellen Gould Chadwick, M.D., Edmund Capparelli, Pharm.D., Ram Yogev, M.D., Jorge Pinto, M.D., D.Sc., Brian Robbins, Ph.D., John H. Rodman, Pharm.D., Jie (Ellen) Chen, M.S., Paul Palumbo, M.D., Leslie Serchuck, M.D., Elizabeth (Betsy) Smith, M.D., Michael Hughes, Ph.D. Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results. AIDS. 2008 Jan 11; 22(2):249 - 255. PMID: 18097227.

Year

2008

Journal

AIDS

Study

P1030

DNR and/or hospice care, psychological health and quality of life among children/adolescents with AIDS.

Maureen E. Lyon, Ph.D., Paige L. Williams, Ph.D., Elizabeth R. Woods, M.D., M.P.H., Nancy Hutton, M.D., Anne Butler, M.S., Erica M. S. Sibinga, M.D., Michael T. Brady, M.D., James M. Oleske, M.D. DNR and/or hospice care, psychological health and quality of life among children/adolescents with AIDS. Journal of Palliative Medicine. 2008 Apr 01; 11(3):459-69. PMID: 18363489; PMCID: PMC2782484.

Year

2008

Journal

Journal of Palliative Medicine

Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics

E V Capparelli, F Aweeka, J Hitti, A Stek, C Hu, S K Burchett, B Best, E Smith, J S Read, H Watts, S Nachman, E M Thorpe Jr, S A Spector, E Jimenez, W T Shearer, M Foca, M Mirochnick, PACTG 1026S Study Team, PACTG P1022 Study Team. Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics. HIV Medicine. 2008 Apr 01; 9(4):214-20. PMID: 18366444; PMCID: PMC2755564.

Year

2008

Journal

HIV Medicine

Study

P1022, P1026S

Diagnosis of human immunodeficiency virus type 1 infection in infants by use of dried blood spots and an ultrasensitive p24 antigen assay.

Ada Cachafeiro, Gayle G. Sherman, A. Sohn, C. Beck-Sague, Susan A. Fiscus, Ph.D. Diagnosis of human immunodeficiency virus type 1 infection in infants by use of dried blood spots and an ultrasensitive p24 antigen assay. Journal of Clinical Microbiology. 2008 Dec 10; 47(2):459-62. PMID: 19073872; PMCID: PMC2643698.

Year

2008

Journal

Journal of Clinical Microbiology

Safety and Immunogenicity of Recombinant Poxvirus HIV-1 Vaccines in Young Adults on Highly Active Antiretroviral Therapy

Thomas C. Greenough, M.D., Coleen K. Cunningham, M.D., Petronella Muresan, M.S., Margaret McManus, B.S., Deborah Persaud, M.D., Terence Fenton, Ed.D., Piers Barker, M.D., Aditya Gaur, M.D., Dennis Panicali, Ph.D., John L. Sullivan, M.D., Katherine Luzuriaga, M.D. Safety and Immunogenicity of Recombinant Poxvirus HIV-1 Vaccines in Young Adults on Highly Active Antiretroviral Therapy. Vaccine. 2008 Oct 20; 26(52):6883-93. PMID: 18940219; PMCID: PMC2845914.

Year

2008

Journal

Vaccine

Study

P1059

Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS clinical trials group) study 5152s

Francesca J. Torriani, M.D., Lauren Komarow, M.S., Robert A. Parker, Sc.D., Bruno R. Cotter, M.D., Judith Silverstein Currier, M.D., M.Sc., Michael P. Dube, M.D., Carl J. Fichtenbaum, M.D., Mariana Gerschenson, Ph.D., Carol K. Mitchell, Robert L. Murphy, M.D., Kathleen E. Squires, M.D., James H. Stein, M.D. Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS clinical trials group) study 5152s. Journal of the American College of Cardiology. 2008 Aug 12; 52(7):569-76. PMCID: PMC2603599.

Year

2008

Journal

Journal of the American College of Cardiology

Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk

Pablo Tebas, M.D., W. Keith Henry, M.D., Roy Matining, M.S., Deborah Weng-Cherng, M.S., John L. Schmitz, Ph.D., Hernan Valdez, M.D., Nasreen Jahed, M.P.H., Laurie S. Myers, M.S., M.T. (A.S.C.P.), William G. Powderly, M.D., David Katzenstein, M.D. Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk. Public Library of Science One. 2008 Apr 23; 3(4):1-6. PMCID: PMC2292263.

Year

2008

Journal

Public Library of Science One

Class-sparing regimens for initial treatment of HIV-1 infection

Sharon A. Riddler, M.D., M.P.H., Richard H. Haubrich, M.D., Greg DiRienzo, Ph.D., Lynne Peeples, M.S., William G. Powderly, M.D., Karin L. Klingman, M.D., Kevin W. Garren, Ph.D., Tania George, Pharm.D., James F. Rooney, M.D., Barbara Brizz, M.H.S.Ed., B.S.N., Umesh Gangharam Lalloo, M.D., F.R.C.P., Robert L. Murphy, M.D., Susan Swindells, M.B.B.S., Diane V. Havlir, M.D., John W. Mellors, M.D. Class-sparing regimens for initial treatment of HIV-1 infection. New England Journal of Medicine. 2008 May 15; 358(20):2095-106.

Year

2008

Journal

New England Journal of Medicine